scholarly journals p27 Activates CDK4 and Blocks Palbociclib-Mediated CDK4 Inhibition

2020 ◽  
Vol 10 (2) ◽  
pp. 172.2-172
Keyword(s):  
2001 ◽  
Author(s):  
Ravichandran N. Venkataramani ◽  
Ronen Marmorstein

2019 ◽  
Author(s):  
Lara E. Davis ◽  
Kevin Nusser ◽  
Janet Pittsenbarger ◽  
Sierra Bertolone-Smith ◽  
Phil Norr ◽  
...  
Keyword(s):  
Phase Ib ◽  

2004 ◽  
Vol 24 (17) ◽  
pp. 7538-7547 ◽  
Author(s):  
Paula L. Miliani de Marval ◽  
Everardo Macias ◽  
Robert Rounbehler ◽  
Piotr Sicinski ◽  
Hiroaki Kiyokawa ◽  
...  

ABSTRACT The proto-oncogene c-myc encodes a transcription factor that is implicated in the regulation of cellular proliferation, differentiation, and apoptosis and that has also been found to be deregulated in several forms of human and experimental tumors. We have shown that forced expression of c-myc in epithelial tissues of transgenic mice (K5-Myc) resulted in keratinocyte hyperproliferation and the development of spontaneous tumors in the skin and oral cavity. Although a number of genes involved in cancer development are regulated by c-myc, the actual mechanisms leading to Myc-induced neoplasia are not known. Among the genes regulated by Myc is the cyclin-dependent kinase 4 (CDK4) gene. Interestingly, previous studies from our laboratory showed that the overexpression of CDK4 led to keratinocyte hyperproliferation, although no spontaneous tumor development was observed. Thus, we tested the hypothesis that CDK4 may be one of the critical downstream genes involved in Myc carcinogenesis. Our results showed that CDK4 inhibition in K5-Myc transgenic mice resulted in the complete inhibition of tumor development, suggesting that CDK4 is a critical mediator of tumor formation induced by deregulated Myc. Furthermore, a lack of CDK4 expression resulted in marked decreases in epidermal thickness and keratinocyte proliferation compared to the results obtained for K5-Myc littermates. Biochemical analysis of the K5-Myc epidermis showed that CDK4 mediates the proliferative activities of Myc by sequestering p21Cip1 and p27Kip1 and thereby indirectly activating CDK2 kinase activity. These results show that CDK4 mediates the proliferative and oncogenic activities of Myc in vivo through a mechanism that involves the sequestration of specific CDK inhibitors.


2017 ◽  
Author(s):  
Jingyu Chen ◽  
Ian T Lobb ◽  
Pierre Morin ◽  
Sonia M Novo ◽  
James Simpson ◽  
...  

Abstractp53 as an effector of nucleolar stress is well defined, but p53 independent mechanisms are largely unknown. Like p53, the NF-κB transcription factor plays a critical role in maintaining cellular homeostasis under stress. Many stresses that stimulate NF-κB also disrupt nucleoli. However, the link between nucleolar function and activation of the NF-κB pathway is as yet unknown. Here we demonstrate that siRNA silencing of PolI complex components stimulates NF-κB signalling. Unlike p53 nucleolar stress response, this effect does not appear to be linked to inhibition of rDNA transcription. We show that specific stress stimuli of NF-κB induce degradation of a critical component of the PolI complex, TIF-IA. This degradation precedes activation of the NF-κB pathway and is associated with an atypical nucleolar architecture. It is mimicked by CDK4 inhibition and is dependent upon upstream binding factor (UBF) and p14ARF. We show that blocking stress effects on TIF-IA blocks their ability to activate the NF-κB pathway. Finally, usingex vivoculture, we show a strong correlation between degradation of TIF-IA and activation of NF-κB in freshly resected, human colorectal tumours exposed to the chemopreventative agent, aspirin. Together, our study provides compelling evidence for a new, NF-κB nucleolar stress response pathway that has in vivo relevance and therapeutic implications.


2018 ◽  
Vol 9 (9) ◽  
Author(s):  
Anusha Sriraman ◽  
Antje Dickmanns ◽  
Zeynab Najafova ◽  
Steven A. Johnsen ◽  
Matthias Dobbelstein

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Manuel Kaulich ◽  
Verena M. Link ◽  
John D. Lapek ◽  
Yeon J. Lee ◽  
Christopher K. Glass ◽  
...  

AbstractDuring early G1 phase, Rb is exclusively mono-phosphorylated by cyclin D:Cdk4/6, generating 14 different isoforms with specific binding patterns to E2Fs and other cellular protein targets. While mono-phosphorylated Rb is dispensable for early G1 phase progression, interfering with cyclin D:Cdk4/6 kinase activity prevents G1 phase progression, questioning the role of cyclin D:Cdk4/6 in Rb inactivation. To dissect the molecular functions of cyclin D:Cdk4/6 during cell cycle entry, we generated a single cell reporter for Cdk2 activation, RB inactivation and cell cycle entry by CRISPR/Cas9 tagging endogenous p27 with mCherry. Through single cell tracing of Cdk4i cells, we identified a time-sensitive early G1 phase specific Cdk4/6-dependent phosphorylation gradient that regulates cell cycle entry timing and resides between serum-sensing and cyclin E:Cdk2 activation. To reveal the substrate identity of the Cdk4/6 phosphorylation gradient, we performed whole proteomic and phospho-proteomic mass spectrometry, and identified 147 proteins and 82 phospho-peptides that significantly changed due to Cdk4 inhibition in early G1 phase. In summary, we identified novel (non-Rb) cyclin D:Cdk4/6 substrates that connects early G1 phase functions with cyclin E:Cdk2 activation and Rb inactivation by hyper-phosphorylation.


2007 ◽  
Vol 373 (4) ◽  
pp. 990-1005 ◽  
Author(s):  
Anjali Mahajan ◽  
Yi Guo ◽  
Chunhua Yuan ◽  
Christopher M. Weghorst ◽  
Ming-Daw Tsai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document